SCHEMBL94252

SCHEMBL94252

O=C(O)CCC(=O)Nc1ccccc1

nearest known ligand 0.89

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.89
CYP1A1 P04798 1/20 0.71
MAPT P10636 2/20 0.71
MEN1 O00255 1/20 0.71
KMT2A Q03164 1/20 0.71
BCHE P06276 1/20 0.69
POLB P06746 1/20 0.69
CYP1A2 P05177 1/20 0.66
HTT P42858 1/20 0.66
SMN1; SMN2 Q16637 1/20 0.65
HDAC4 P56524 5/20 0.62
HDAC1 Q13547 5/20 0.62
HDAC7 Q8WUI4 5/20 0.62
HDAC11 Q96DB2 5/20 0.62
HDAC8 Q9BY41 5/20 0.62
HDAC6 Q9UBN7 5/20 0.62
HDAC9 Q9UKV0 5/20 0.62
HDAC5 Q9UQL6 5/20 0.62
HDAC3 O15379 4/20 0.62
HDAC2 Q92769 4/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3342586 0.93 L3MBTL1 (0.80) L3MBTL1MAPTCYP1A2HTTSMN1; SMN2
SCHEMBL19353947 0.92 L3MBTL1 (0.77) L3MBTL1CYP1A1MAPTMEN1KMT2A
SCHEMBL6766490 0.92 L3MBTL1 (0.77) L3MBTL1CYP1A1MAPTMEN1KMT2A
SCHEMBL1060805 0.88 HDAC4 (0.73) L3MBTL1MAPTMEN1KMT2APOLB
SCHEMBL3806017 0.88 MEN1 (0.73) L3MBTL1MAPTMEN1KMT2APOLB
SCHEMBL1064861 0.86 HDAC4 (0.77) L3MBTL1MAPTMEN1KMT2AHDAC4
SCHEMBL312344 0.86 HDAC4 (0.77) L3MBTL1MAPTMEN1KMT2AHDAC4
SCHEMBL14533437 0.85 ALDH1A1 (0.69) L3MBTL1CYP1A1MAPTMEN1KMT2A
SCHEMBL19353945 0.85 CYP1A1 (0.75) L3MBTL1CYP1A1MAPTMEN1KMT2A
SCHEMBL12112926 0.85 MAPT (0.79) L3MBTL1MAPTPOLBHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 144 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4694882-A2 COMPOUNDS FOR TREATING RETT SYNDROME AND OTHER DISORDERS Unravel Biosciences, Inc. (US) 2026-02-18 EP claimed
WO-2024258929-A1 METHODS FOR TREATING DISEASES ASSOCIATED WITH TAF1 LOSS OF FUNCTION UNRAVEL BIOSCIENCES, INC. (US) 2024-12-19 WO claimed
WO-2024215967-A2 COMPOUNDS FOR TREATING RETT SYNDROME AND OTHER DISORDERS UNRAVEL BIOSCIENCES, INC. (US) 2024-10-17 WO claimed
EP-4015488-A1 METHOD FOR PRODUCING AN AMMONIUM-BASED SOLID, PARTICULATE COMPOSITION COMPRISING AN ADDITIVE Yara International ASA (NO) 2022-06-22 EP claimed
EP-4694882-A2 COMPOUNDS FOR TREATING RETT SYNDROME AND OTHER DISORDERS Unravel Biosciences, Inc. (US) 2026-02-18 EP disclosed
EP-4694882-A2 COMPOUNDS FOR TREATING RETT SYNDROME AND OTHER DISORDERS Unravel Biosciences, Inc. (US) 2026-02-18 EP disclosed
US-20250258146-A1 QUANTITATIVE DETECTION METHOD OF MULTIPLE METABOLITES IN BIOLOGICAL SAMPLE AND METABOLIC CHIP HUMAN METABOLOMICS INSTITUTE INC. (CN) 2025-08-14 US disclosed
WO-2024215967-A3 COMPOUNDS FOR TREATING RETT SYNDROME AND OTHER DISORDERS UNRAVEL BIOSCIENCES, INC. (US) 2025-02-20 WO disclosed
CN-113249112-B Quantum dot and application thereof 东友精细化工有限公司 2025-02-07 CN disclosed
WO-2024258929-A1 METHODS FOR TREATING DISEASES ASSOCIATED WITH TAF1 LOSS OF FUNCTION UNRAVEL BIOSCIENCES, INC. (US) 2024-12-19 WO disclosed
WO-2024215967-A2 COMPOUNDS FOR TREATING RETT SYNDROME AND OTHER DISORDERS UNRAVEL BIOSCIENCES, INC. (US) 2024-10-17 WO disclosed
WO-2024215967-A2 COMPOUNDS FOR TREATING RETT SYNDROME AND OTHER DISORDERS UNRAVEL BIOSCIENCES, INC. (US) 2024-10-17 WO disclosed
US-4588833-A CARBON MONOXIDE, ALCOHOL OR AMINE, ACID, UNSATURATED AMIDE, COBALTCOMPOUND BAYER AKTIENGESELLSCHAFT (DE) 1986-05-13 US disclosed
US-4393220-A FUNGICIDES CONSORTIUM FUR ELEKTROCHEMISCHE INDUSTRIE GMBH (DE) 1983-07-12 US disclosed
US-4352807-A Hexahydro-trans-pyridoindole neuroleptic agents PFIZER INC. (US) 1982-10-05 US disclosed
US-4252811-A Hexahydro-trans-pyridoindole neuroleptic agents PFIZER INC. (US) 1981-02-24 US disclosed
US-4117531-A VALVE METAL ELECTRODES, AMMONIUM OR AMINE SALT OF MALEAMIC, SUCCINAMIC, PHTHALAMIC, OR HEXAHYDROPHTHALAMIC ACID IN DIMETHYLFORMAMIDE, N-METHYLFORMAMIDE, GLYCOL, OR GLYCOL-METHYLCELLOSOLVE SPRAGUE ELECTRIC COMPANY (US) 1978-09-26 US disclosed
US-4009278-A Antimicrobial composition and method containing N-(3,5-dihalophenyl)-imide compounds SUMITOMO CHEMICAL COMPANY, LIMITED (JA) 1977-02-22 US disclosed
US-4004074-A ADDITION COPOLYMERS HAVING BINDING AND SUNSCREEN GROUPS COLGATE-PALMOLIVE COMPANY (US) 1977-01-18 US disclosed
US-4004074-A ADDITION COPOLYMERS HAVING BINDING AND SUNSCREEN GROUPS COLGATE-PALMOLIVE COMPANY (US) 1977-01-18 US disclosed